News
FDA Approval Surge: Enhertu Gains Dual Early Breast Cancer Indications, Tecentriq First ct DNA-Guided Adjuvant in Bladder Cancer, Baxfendy Introduces First Aldosterone Synthase Inhibitor for Hypertension, and More
1+ hour, 30+ min ago (232+ words) drugscontrol. org - CDSCO Public Notice Clarifies: Injectable Preparations Are NOT Cosmetics " No Cosmetic Permitted for Injection by Consumers, Professionals or Aesthetic Clinics; Strict Enforcement Under Drugs & Cosmetics Act, 2020 Rules (19-05-2026) - Expanding Quackery Crisis: Fake Doctors, Illegal Hospitals, Unregistered Clinics and Drug…...
Gene editing can make blood cancer treatment safer and more powerful
2+ hour, 28+ min ago (464+ words) ...
Conexeu Sciences Advances 3 D Biofabricated Matrix to Move Breast Reconstruction Beyond Implants
1+ hour, 11+ min ago (293+ words) B. R. E. A. S. T." was developed using Conexeu's proprietary CXU" platform, an extracellular matrix (ECM)-based biofabrication technology. B. R. E. A. S. T." introduces a new implantable device in soft tissue restoration: a resorbable and bioregenerative matrix engineered to guide the patient's own cells towards the formation of new…...
Rep. Richardson Supports Amendment to Prevent Mandatory Vaccination of COVID-19
2+ hour, 46+ min ago (16+ words) Ohio House of Representatives (. gov)...
Zenas Bio Pharma Announces Upcoming Presentation of Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4-Related Disease (Ig G4-RD) at EULAR 2026 Congress
1+ hour ago (419+ words) The Manila Times Zenas Bio Pharma Announces Upcoming Presentation of Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4-Related Disease (Ig G4-RD) at EULAR 2026 Congress - Safety and efficacy results from the Phase 3 INDIGO trial to be presented by…...
Astra Zeneca wins US approval for first'in'class Baxfendy in hypertension
2+ hour, 9+ min ago (307+ words) by John Pinching | 19th May 2026 | News The decision is based on positive phase 3 Bax HTN results showing statistically significant and clinically meaningful reductions in systolic blood pressure. Hypertension affects 1. 4 billion people worldwide, with around half of US patients continuing to experience…...
Plus Therapeutics Partners with Ephemeral Technologies to Deploy AI Execution Platform for CNS Oncology
1+ hour, 26+ min ago (448+ words) The Manila Times Plus Therapeutics Partners with Ephemeral Technologies to Deploy AI Execution Platform for CNS Oncology Partnership to deliver a novel AI-native integrated CNS oncology platform Platform will unify and analyze Plus" proprietary therapeutic, diagnostic, and bioinformatics datasets to…...
US states reject anti-vaccine bills as public health groups fight MAHA
23+ hour, 4+ min ago (68+ words) Dailyhunt US states reject anti-vaccine bills as public health groups fight MAHA WASHINGTON, May 18 - Dozens of state anti-vaccine bills backed by \"Make America Healthy Again\" supporters have failed after public health groups won over Republican state lawmakers, marking a series…...
Congo-Kinshasa: What You Need to Know About the Ebola Outbreak That Has the Who Concerned
6+ hour, 33+ min ago (791+ words) The World Health Organization has declared the Ebola outbreak in West Africa a public health emergency of international concern. So far, 336 people have been infected in the central African and East African countries of Uganda and the Democratic Republic of…...
Police launch on spot drug testing for drivers
8+ hour, 55+ min ago (20+ words) The Times of India - Police launch on spot drug testing for drivers...